M. Haller et al., CONTINUOUS INTRAVASCULAR BLOOD GLAS ANALY SIS - CLINICAL-EVALUATION OF A NEW FIBER OPTIC MONITOR, Anasthesist, 43(10), 1994, pp. 642-647
Continuous monitoring of blood gases and pH could add substantially to
patient safety. During the last decade, efforts have been made to dev
elop continuous optochemical blood gas sensors. The initial evaluation
of such fibreoptic-based systems showed major patient-interface probl
ems [11]. We evaluated a new intra-arterial blood gas monitoring syste
m (PB3300, Puritan-Bennett, Carlsbad CA) under routine clinical condit
ions. Methods. After institutional review board approval and with writ
ten informed consent, 38 sensors were tested in 25 patients with acute
respiratory failure (e.g., the acute respiratory distress syndrome, c
omplications after lung transplantation). Two conventional bench-top b
lood gas analysers (ABL 520 and ABL 300, Radiometer, Copenhagen) serve
d as criterion standards. The mean differences (bias) and standard dev
iations (SD) of the differences (precision) were calculated according
to the method of Bland and Altman [2]. In addition, linear regression
analysis and correlation coefficients were calculated. The quality of
blood pressure tracings was assessed using a grading system. Results.
The median sensor lifetime was 81.3 h; 869 blood samples (median 14 pe
r sensor) were analysed for the comparison of continuous and conventio
nal blood gas analysis. The ranges for measured parameters were: pH: 6
.92 to 7.55; PCO2: 20 to 83 torr; PO2: 31 to 518 torr. The mean differ
ences (SD) were: pH: -0.03 (0.03) or -0.4 (0.4)%; PCO2: -2.6 (4.1) tor
r or -6.9 (10.9)%; PO2: -3.4 (10.5) torr or -2.9 (7.0)%. The results o
f linear regression analysis and the correlation coefficients are depi
cted in Table 2. The mean grade of blood pressure tracings was satisfa
ctory for the clinical setting. Conclusions. The continuous blood gas
monitor is sufficiently accurate and precise for clinical use. Bias an
d precision are better than those known from former studies evaluating
fibreoptic blood gas monitors under experimental conditions [7]. Cost
-effectiveness was not an issue of this study.